1Moreno MG,Muriel P.Remission of liver fibrosis by interferon-alpha 2b.Biochem Pharmacol,1995,50:515-520.
2Hung KS,Lee TH,Chou W Y,et al.Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice.Bioebem Bioph Res Co,2005,336:324-331.
3Stadlbauer V,Mookerjee RP,Hodges S,et al.Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis.J Hepatol,2008,48:945-951.
4Rosenbloom J,Castro SV,Jimenez SA.Narrative review:fibrotic diseases:cellular and molecular mechanisms and novel therapies.Ann Intern Med,2010,152:159-166.
5Beham-Schmid C,Apfelbeck U,Sill H,et al.Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis.Blood,2002,99:381-383.
6Yoshiji H,Noguchi R,Kuriyama S,et al.Imatinib mesylate(STI-571)attenuates liver fibrosis development in rats.Am J Physiol Gastrointest Liver Physiol,2005,288:G907-913.
7Chen SW,Chen YX,Xie WF,et al.Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats.Gene Ther,2008,15:1424-1435.
8Lebrec D,Thabut D,Oberti F,et al.Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis.Gastroenterology,2010,138:1755-1762.
9Zhong W,Shen WF,Xie WF,et al.Inhibition of extracellular signalregulated kinase 1 by adenovirus mediated small interfering RNA attenuates hepatic fibrosis in rats.Hepatology,2009,50:1524-1536.
10KJ Wohlschlaeger J,Lang H,Sotiropoulos GC,et al.Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection.J Hepatol,2008,48:83-90.
